Cagrilintide (10mg) Cagrilintide - Long-acting amylin analog activating AMY1R/AMY2R/AMY3R and CALCR receptors. ≥98% purity (HPLC). Half-life 159-195 hours. For laboratory research only. Manufacturer: RiboCore Availability: 100 in stock SKU: RP-CAGR-10MG $99.00 Qty: Add to cart Ship to Select country United States of America Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia (Plurinational State of) Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo (Democratic Republic of the) Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czechia Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea (Democratic People's Republic of) Korea (Republic of) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia (Federated States of) Moldova (Republic of) Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe * Other * Shipping Method Name Estimated Delivery Price No shipping options Apply Custom wishlist OK Add to wishlist Add to compare list Email a friend Cagrilintide (RP-CAGR-10MG) Research Peptide Molecular Profile: - Molecular Formula: C₁₉₄H₂₉₆N₅₄O₅₉S₂ (with C20 fatty acid modification) - Molecular Weight: ~4,400 Da - CAS Number: Not yet assigned (investigational compound) - Sequence Homology: 84% to native human amylin - Key Modifications: C20 fatty acid lipidation at Lys1, strategic amino acid substitutions (N14E, V17R, P25, P28, P29, P37Y) enabling extended half-life and preventing amyloid fibril formation - Half-Life: 159-195 hours (vs. minutes for native amylin) - Purity: ≥98% (HPLC) Research Applications: Cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA) designed for investigating metabolic regulation mechanisms. The compound activates heterodimeric CALCR/RAMP receptor complexes (AMY1R, AMY2R, AMY3R) and enables research into: - CNS satiety circuit mapping via area postrema, nucleus tractus solitarius, and lateral parabrachial nucleus activation pathways - RAMP-mediated GPCR pharmacology investigating AMY1R (RAMP1) and AMY3R (RAMP3) weight-lowering mechanisms - Postprandial glucose regulation through gastric emptying modulation and glucagon suppression pathways - Synergistic metabolic pathway analysis in combination therapy models (amylin + GLP-1 receptor co-activation) - Structure-function relationship studies using cryo-EM validated peptide-receptor interaction determinants - Gut-brain axis communication mechanisms via vagal afferent signaling and circumventricular organ pathways Product Specifications: - Appearance: White to off-white lyophilized powder - Solubility: Soluble in water, PBS, or saline (pH 7.0-7.4) - Storage: -20°C, protected from light - Stability: 24 months when stored properly - Quality Control: Mass spectrometry identity confirmation, <1.0 EU/mg endotoxins - Certificate of Analysis: Provided with each batch Laboratory Use Only: This product is intended solely for in-vitro laboratory research by qualified researchers in appropriate research facilities. NOT approved for human consumption, medical use, clinical applications, or diagnostic purposes. Researchers must comply with all applicable regulations and maintain proper institutional oversight. By purchasing, buyer confirms understanding this product is sold strictly for laboratory research in controlled settings. Structural Data Reference: RCSB PDB 7BG0